Dermatitis and eczema Skin and Connective Tissue Diseases Dermatitis and eczema
Conditions
Interventions
In the present study, eligible participants will be identified through a search of the GP practice database. Participants will be randomised at the practice level and for those assigned to the interve
Sponsors
Rotherham, Doncaster, and South Humber NHS Foundation Trust (RDaSH)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Parents of children aged 6 months - 6 years with a diagnosis of atopic eczema made by a GP or an appropriately qualified health care professional recorded in their medical notes 2. Children currently prescribed (prescriptions issued for the previous three months) one or more of the following treatments: 2.1. Any emollient products e.g. creams, ointments, bathing products, etc. 2.2. Topical steroids 2.3. Topical immunomodulators
Exclusion criteria
Exclusion criteria: 1. Parents (or carers) without adequate spoken and written English, as determined by the pharmacist, will be excluded as the study does not have sufficient funding to allow for the provision of an interpreter or for the education information to be translated into other languages 2. Children under the care of a dermatologist or other dermatology specialist 3. Children attending any specialist nurse-led eczema clinic Children in the above categories are excluded because it is assumed that they will have received sufficient educational support and are therefore unlikely to benefit from additional advice
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eczema severity measured using Patient-Oriented Eczema Measure (POEM) score at baseline and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Eczema care knowledge and understanding among parents/carers measured using the Person-centred dermatology self care index (PeDesi) at baseline and 4 weeks | — |
Countries
England, United Kingdom
Contacts
Public ContactJeannie McKie
Outcome results
None listed